Skip to main content

Andelyn Biosciences manufacturing facility ready for clients as company seeks CEO

The 250,000-square-foot commercial-scale manufacturing facility for the genetic material and delivery viruses needed for gene therapy is "ready for client production," the spinoff from Nationwide Children's Hospital announced in a LinkedIn post last week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.